Physician profile
Andrew Chen
NPI 1740623958
$56,347.09
in general payments reported to CMS, 2019-2025
19 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,411 · 2020: $18K · 2021: $2,653 · 2022: $514 · 2023: $3,827 · 2024: $14K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $5,407 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Grant: $3,036 · Travel and Lodging: $1,990 · Education: $16.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,440.20 |
| Food and Beverage | $5,407.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Grant | $3,036.00 |
| Travel and Lodging | $1,989.65 |
| Education | $16.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $14,054.72 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Boston Scientific Corporation | $13,483.18 | 2019-2025 | Rhythmia Mapping System, Watchman, Accolade Sr |
| Medtronic Vascular, INC. | $12,936.73 | 2020 | |
| Medtronic, INC. | $11,059.01 | 2021-2025 | Micra, Pulseselect, Attain Command + Surevalve |
| Medical Device Business Services, INC. | $2,066.56 | 2023-2024 | Carto 3 |
| Biotronik INC. | $697.40 | 2021-2024 | Acticor 7 Vr-T Dx, Amvia Edge |
| Cardiva Medical, INC. | $632.02 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Abbott Laboratories | $601.51 | 2021-2023 | Ensite |
| Procept Biorobotics Corporation | $198.44 | 2023 | Aquabeam Robotic System |
| Atricure, INC. | $157.92 | 2021-2023 | |
| Impulse Dynamics (USA) INC. | $154.11 | 2025 | Optimizer |
| Shockwave Medical, INC | $96.87 | 2025 | |
| Novartis Pharmaceuticals Corporation | $52.98 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.59 | 2023 | Lifevest |
| Philips North America LLC | $32.55 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.97 | 2020 | |
| Abiomed | $22.99 | 2025 | |
| Chiesi USA, INC. | $16.27 | 2024 | Cleviprex, Kengreal |
| Novo Nordisk INC | $16.27 | 2025 | Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.